Physicians see ‘new era for weight loss medications’ with the arrival of Novo, Lilly GLP-1 meds, survey says
Physicians are calling out two new obesity treatments — tirzepatide and semaglutide — as “paradigm shifting,” according to a new survey from InCrowd …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
